The purpose of this study is to learn more about the number of female collegiate athletes who fall in the "at-risk"category for developing low energy availability. Low energy availability can cause an increased risk of developing a musculoskeletal injury. If we can learn how common the condition is, then we can work to develop better strategies for screening purposes.

Do you have advanced or metastatic non small cell lung cancer, squamous cell carcinoma of the head and neck, colorectal cancer, or renal cell carcionma? Have you tried previous therapies that did not work? If so, you may be able to take part in this study. Investigational study drug is provided.

We are studying how people's daily physical activity and alcohol use behaviors are related to their risk for obesity and inflammation. We are collecting this information to learn more about disease risk and to inform future research studies and interventions.

This study aims to find better ways to serve children with autism spectrum disorder (ASD). We will use 3 rounds of online surveys to develop a list of functionality features that are most relevant for serving school-age autistic children. We hope this list can be used to improve services and support for those who are on the autism spectrum.

Do you have triple negative breast cancer? Have you had surgery following chemotherapy? You may be able to participate in a study to find out if stopping pembrolizumab infusions after surgery is just as effective at reducing your risk of cancer recurrence.

To determine the impacts of low-income status and addiction on current student well-being.

Have you been diagnosed with B-cell post-transplant lymphoproliferative disorder (PTLD) after an organ transplant? Have you not yet received any type of treatment for this condition? Then you may be eligible for a study to look at the safety and effectiveness of tafasitamab and rituximab combination treatment for PTLD.

Help shape the future of lupus! Do you want to provide a game-changing contribution to lupus-centered research? Help us make clinical research more efficient and effective. If you have lupus, you can participate by providing samples we can study, such as blood, urine, saliva, and/or stool, to help doctors combat lupus head-on. Compensation provided.

The purpose of this research study is to explore common experiences related to forming stepfamily relationships (and it's completely okay if you do not identify as a "stepfamily").

The purpose of this study is to find out if we can improve the chance of your leukemia going away (remission) and lower the chance of your leukemia coming back (relapsing) by combining two drugs for acute lymphoblastic leukemia. In this study you will be given the first study drug (Inotuzumab Ozogamicin) for up to 7 weeks and then a second leukemia drug (Blinatumomab) for up to 31 weeks.